HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tatsuo Kohriyama Selected Research

Stroke (Strokes)

1/2022Association between the Suita Score and Stroke Recurrence in Patients with First-ever Ischemic Stroke: A Prospective Cohort Study.
10/2019Development of Quality Indicators of Stroke Centers and Feasibility of Their Measurement Using a Nationwide Insurance Claims Database in Japan　― J-ASPECT Study ―
9/2018Can the Amount of Interventions during the Convalescent Phase Predict the Achievement of Independence in Activities of Daily Living in Patients with Stroke? A Retrospective Cohort Study.
9/2015The Japan Statin Treatment Against Recurrent Stroke (J-STARS): A Multicenter, Randomized, Open-label, Parallel-group Study.
7/2014Safety evaluation of substituting clopidogrel for ticlopidine in Japanese patients with ischemic stroke--Hiroshima ticlopidine, clopidogrel safe exchange trial.
2/2014Rationale, design, and baseline features of a randomized controlled trial to assess the effects of statin for the secondary prevention of stroke: the Japan Statin Treatment Against Recurrent Stroke (J-STARS).
10/2006[J-STARS (Japan statin treatment against recurrent stroke)].
12/2005Clinical characteristics of first-ever atherothrombotic infarction or lacunar infarction with hyperlipidemia (J-STARS-C): an analysis of data from the stroke data bank of Japan.
3/2002Endothelial markers and adhesion molecules in acute ischemic stroke--sequential change and differences in stroke subtype.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tatsuo Kohriyama Research Topics

Disease

9Stroke (Strokes)
01/2022 - 03/2002
4Parkinson Disease (Parkinson's Disease)
01/2017 - 03/2002
3Ischemic Stroke
09/2015 - 03/2002
3Multiple Sclerosis
03/2011 - 08/2003
3Hypoxia (Hypoxemia)
03/2008 - 11/2006
2Infarction (Infarctions)
09/2015 - 03/2002
2Ischemia
11/2006 - 11/2003
2Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
04/2004 - 04/2003
1Aspiration Pneumonia
01/2022
1Atherosclerotic Plaque (Atheroma)
01/2021
1Periodontal Pocket (Periodontal Pockets)
01/2021
1Periodontitis
01/2021
1Hypertensive Intracranial Hemorrhage
01/2021
1Myasthenia Gravis
05/2020
1Atrial Fibrillation
10/2019
1Dysgeusia (Parageusia)
05/2019
1Guillain-Barre Syndrome
01/2017
1Atherosclerosis
09/2015
1Transient Ischemic Attack
07/2014
1Hyperlipidemias (Hyperlipidemia)
02/2014
1Miller Fisher Syndrome (Fisher Syndrome)
12/2012
1Alexander Disease (Alexander's Disease)
06/2009
1Leukocytosis (Pleocytosis)
04/2009
1Dyskinesias (Dyskinesia)
09/2008
1Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
08/2008
1Motor Neuron Disease (Primary Lateral Sclerosis)
08/2008
1Opticospinal Multiple Sclerosis
06/2008
1Disease Progression
06/2008
1Headache (Headaches)
03/2008
1Seizures (Absence Seizure)
03/2008
1Limbic Encephalitis (Paraneoplastic Limbic Encephalitis)
12/2006
1Thymoma (Thymic Carcinoma)
12/2006
1Hypertrophy
04/2004
1Brain Ischemia (Cerebral Ischemia)
11/2003
1Human Influenza (Influenza)
08/2003
1Cardiotoxicity
08/2003
1Polyneuropathies (Polyneuropathy)
04/2003
1Parkinsonian Disorders (Parkinsonism)
03/2002

Drug/Important Bio-Agent (IBA)

4Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
09/2015 - 12/2005
4Proteins (Proteins, Gene)FDA Link
04/2009 - 04/2004
3UbiquitinIBA
08/2008 - 11/2003
2Carrier Proteins (Binding Protein)IBA
01/2021 - 08/2006
2MethylprednisoloneFDA LinkGeneric
05/2020 - 03/2008
2Therapeutic UsesIBA
01/2017 - 03/2002
2Pravastatin (Pravachol)FDA LinkGeneric
09/2015 - 02/2014
2AntibodiesIBA
12/2012 - 12/2006
2Mixed Function Oxygenases (Monooxygenases)IBA
03/2008 - 02/2007
1AlbuminsIBA
01/2022
1Dexamethasone Isonicotinate (HE 111)IBA
01/2022
1LipidsIBA
01/2022
1CollagenIBA
01/2021
1Antihypertensive Agents (Antihypertensives)IBA
10/2019
1fasudil (AT 877)IBA
10/2019
1SodiumIBA
10/2019
1ozagrelIBA
10/2019
1Ticlopidine (Ticlid)FDA LinkGeneric
07/2014
1Clopidogrel (Plavix)FDA Link
07/2014
1CholesterolIBA
02/2014
1Glial Fibrillary Acidic ProteinIBA
06/2009
1Immunoglobulin G (IgG)IBA
04/2009
1Levodopa (L Dopa)FDA LinkGeneric
09/2008
1Interferon-betaIBA
06/2008
1Neutralizing AntibodiesIBA
06/2008
1Prolyl Hydroxylases (Prolyl Hydroxylase)IBA
03/2008
1Cyclosporine (Ciclosporin)FDA LinkGeneric
03/2008
1Prednisolone (Predate)FDA LinkGeneric
03/2008
1Ligases (Synthetase)IBA
02/2007
1Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA
12/2006
1Small Interfering RNA (siRNA)IBA
11/2006
1rhoA GTP-Binding ProteinIBA
11/2006
1Monomeric GTP-Binding ProteinsIBA
11/2006
1rho-Associated KinasesIBA
11/2006
1alpha-SynucleinIBA
08/2006
1Heat-Shock Proteins (Heat-Shock Protein)IBA
11/2003
1Proteasome Endopeptidase Complex (Proteasome)IBA
11/2003
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
11/2003
1Cell Adhesion MoleculesIBA
11/2003
1Myelin Basic ProteinIBA
08/2003
1AntigensIBA
08/2003
1Pharmaceutical PreparationsIBA
08/2003
1Amino AcidsFDA Link
08/2003
1Intravenous Immunoglobulins (IVIG)FDA Link
04/2003
1Macrophage Colony-Stimulating FactorIBA
04/2003
1SelectinsIBA
03/2002
1E-SelectinIBA
03/2002
1P-SelectinIBA
03/2002

Therapy/Procedure

8Therapeutics
05/2020 - 04/2003
2Oral Diagnosis (Oral Examination)
01/2021 - 05/2019
2Activities of Daily Living (ADL)
05/2020 - 09/2018
1Carotid Endarterectomy
01/2021
1Occupational Therapy (Therapy, Occupational)
09/2018
1Speech Therapy (Therapy, Speech)
09/2018
1Medical Day Care (Partial Hospitalization)
01/2017
1Enteral Nutrition (Feeding, Tube)
01/2017
1Gastrostomy
01/2017
1Tracheotomy
01/2017
1Secondary Prevention
02/2014
1Intravenous Administration
03/2008
1Duration of Therapy
08/2003
1Immunomodulation
04/2003